Anand Jeevarethinam1,2, Shreenidhi Venuraju1,2, Alain Dumo3, Sherezade Ruano3, Vishal S Mehta4, Miranda Rosenthal5, Devaki Nair6, Mark Cohen7, Daniel Darko8, Avijit Lahiri1,9,10, Roby Rakhit11. 1. Cardiac Imaging and Research Centre, Wellington Hospital, London, United Kingdom. 2. Institute of Cardiovascular Sciences, University College London, United Kingdom. 3. British Cardiac Research Trust, Cardiac Imaging and Research Centre, Wellington Hospital, London, United Kingdom. 4. Royal Free and UCL Medical School, London, United Kingdom. 5. Department of Diabetes and Endocrinology, Royal Free Hospital, London, United Kingdom. 6. Department of Clinical Biochemistry, Royal Free Hospital, London, United Kingdom. 7. Department of Diabetes and Endocrinology, Barnet Hospital, London, United Kingdom. 8. The Jeffrey Kelson Centre for Diabetes and Endocrinology, Central Middlesex Hospital, London, United Kingdom. 9. Imperial College of Medicine, Imperial College London, UK. 10. Healthcare Science, Middlesex University, London, UK. 11. Department of Cardiology, Royal Free Hospital, London, United Kingdom.
Abstract
BACKGROUND: The value of screening sub-clinical atherosclerosis in asymptomatic patients with type 2 diabetes mellitus (T2DM) remains controversial. HYPOTHESIS: An integrated model incorporating carotid intima-media thickness (CIMT) and carotid plaque with traditional risk factors can be used to predict prevalence and severity of coronary artery calcification in asymptomatic T2DM patients. METHODS: A cohort of 262 asymptomatic T2DM patients were prospectively studied with carotid ultrasound to evaluate CIMT and carotid plaque and also a computed tomography coronary artery calcium (CT-CAC) scan. RESULTS: Carotid plaque was detected in 124 (47%) patients and mean CIMT was 0.75±0.14 mm. Two hundred (76%) patients had a CAC score >0, of whom 57 (22%) had severe coronary atherosclerosis (>400 Au). In this group, carotid plaque was present in 40 (70%) patients (p<0.001). Univariable analysis revealed significant associations between non-zero CAC score and age (p<0.001), hypertension (p=0.01), gender (p=0.003) and duration of diabetes (p=0.004). Carotid plaque and mean CIMT were also significantly associated with non-zero CAC score (odds ratios [95% CI], 3.12 [1.66 -5.85] and 2.98 [0.24 -7.17], respectively). After adjusting for traditional risk factors, carotid plaque continued to be predictive of non-zero CAC score (2.59 [1.17 -5.74]) and CIMT was borderline significant (p=0.05). When analysed with binary logistical regression, the prevalence of carotid plaque significantly predicted severe CAC burden (CAC >400 Au; 3.26 [2.05 -5.19]). Upper CIMT quartiles showed a similar association (2.55 [1.33 -4.87]). CONCLUSION: Carotid plaque is more predictive of underlying silent coronary atherosclerosis prevalence, severity and extent in asymptomatic T2DM patients.
BACKGROUND: The value of screening sub-clinical atherosclerosis in asymptomatic patients with type 2 diabetes mellitus (T2DM) remains controversial. HYPOTHESIS: An integrated model incorporating carotid intima-media thickness (CIMT) and carotid plaque with traditional risk factors can be used to predict prevalence and severity of coronary artery calcification in asymptomatic T2DM patients. METHODS: A cohort of 262 asymptomatic T2DM patients were prospectively studied with carotid ultrasound to evaluate CIMT and carotid plaque and also a computed tomography coronary artery calcium (CT-CAC) scan. RESULTS: Carotid plaque was detected in 124 (47%) patients and mean CIMT was 0.75±0.14 mm. Two hundred (76%) patients had a CAC score >0, of whom 57 (22%) had severe coronary atherosclerosis (>400 Au). In this group, carotid plaque was present in 40 (70%) patients (p<0.001). Univariable analysis revealed significant associations between non-zero CAC score and age (p<0.001), hypertension (p=0.01), gender (p=0.003) and duration of diabetes (p=0.004). Carotid plaque and mean CIMT were also significantly associated with non-zero CAC score (odds ratios [95% CI], 3.12 [1.66 -5.85] and 2.98 [0.24 -7.17], respectively). After adjusting for traditional risk factors, carotid plaque continued to be predictive of non-zero CAC score (2.59 [1.17 -5.74]) and CIMT was borderline significant (p=0.05). When analysed with binary logistical regression, the prevalence of carotid plaque significantly predicted severe CAC burden (CAC >400 Au; 3.26 [2.05 -5.19]). Upper CIMT quartiles showed a similar association (2.55 [1.33 -4.87]). CONCLUSION: Carotid plaque is more predictive of underlying silent coronary atherosclerosis prevalence, severity and extent in asymptomatic T2DM patients.
Authors: Scott M Grundy; Barbara Howard; Sidney Smith; Robert Eckel; Rita Redberg; Robert O Bonow Journal: Circulation Date: 2002-05-07 Impact factor: 29.690
Authors: Philip Greenland; Joseph S Alpert; George A Beller; Emelia J Benjamin; Matthew J Budoff; Zahi A Fayad; Elyse Foster; Mark A Hlatky; John McB Hodgson; Frederick G Kushner; Michael S Lauer; Leslee J Shaw; Sidney C Smith; Allen J Taylor; William S Weintraub; Nanette K Wenger; Alice K Jacobs Journal: Circulation Date: 2010-11-15 Impact factor: 29.690
Authors: James H Stein; Claudia E Korcarz; R Todd Hurst; Eva Lonn; Christopher B Kendall; Emile R Mohler; Samer S Najjar; Christopher M Rembold; Wendy S Post Journal: J Am Soc Echocardiogr Date: 2008-02 Impact factor: 5.251
Authors: P-J Touboul; M G Hennerici; S Meairs; H Adams; P Amarenco; N Bornstein; L Csiba; M Desvarieux; S Ebrahim; M Fatar; R Hernandez Hernandez; M Jaff; S Kownator; P Prati; T Rundek; M Sitzer; U Schminke; J-C Tardif; A Taylor; E Vicaut; K S Woo; F Zannad; M Zureik Journal: Cerebrovasc Dis Date: 2006-11-14 Impact factor: 2.762
Authors: Kristen Franklin; Robert J Goldberg; Frederick Spencer; Werner Klein; Andrzej Budaj; David Brieger; Michel Marre; Philippe Gabriel Steg; Neelam Gowda; Joel M Gore Journal: Arch Intern Med Date: 2004-07-12
Authors: Rafael Simó; Ignacio Ferreira; Jordi Bañeras; Cristina Hernández; José Rodríguez-Palomares; Filipa Valente; Laura Gutierrez; Teresa González-Alujas; Santiago Aguadé-Bruix; Joan Montaner; Daniel Seron; Joan Genescà; Anna Boixadera; José García-Arumí; Alejandra Planas; Olga Simó-Servat; David García-Dorado Journal: BMJ Open Diabetes Res Care Date: 2019-12-29